Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marta Swierczek, Zsuzsanna Izsvák & Zoltán Ivics. (2012) The Sleeping Beauty transposon system for clinical applications. Expert Opinion on Biological Therapy 12:2, pages 139-153.
Read now
Read now
Rupshi Mitra & Robert M Sapolsky. (2010) Gene therapy in rodent amygdala against fear disorders. Expert Opinion on Biological Therapy 10:9, pages 1289-1303.
Read now
Read now
Paola Grandi, Pierpaolo Peruzzi, Bonnie Reinhart, Justus B Cohen, E Antonio Chiocca & Joseph C Glorioso. (2009) Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Review of Neurotherapeutics 9:4, pages 505-517.
Read now
Read now
Delphine Cuchet & Alberto L Epstein. (2008) Further improvements in the technology of HSV-1-based amplicon vectors. Expert Opinion on Therapeutic Patents 18:7, pages 797-804.
Read now
Read now
Articles from other publishers (33)
Arlene Martínez-Rivera, Caitlin E. Burgdorf & Anjali M. Rajadhyaksha. 2021. The Brain Reward System. The Brain Reward System
233
261
.
Xutao Zhu, Kunzhang Lin, Qing Liu, Xinpei Yue, Huijie Mi, Xiaoping Huang, Xiaobin He, Ruiqi Wu, Danhao Zheng, Dong Wei, Liangliang Jia, Weilin Wang, Anne Manyande, Jie Wang, Zhijian Zhang & Fuqiang Xu. (2019) Rabies Virus Pseudotyped with CVS-N2C Glycoprotein as a Powerful Tool for Retrograde Neuronal Network Tracing. Neuroscience Bulletin 36:3, pages 202-216.
Crossref
Crossref
Selene Ingusci, Gianluca Verlengia, Marie Soukupova, Silvia Zucchini & Michele Simonato. (2019) Gene Therapy Tools for Brain Diseases. Frontiers in Pharmacology 10.
Crossref
Crossref
Kenneth Lundstrom. (2019) Gene Therapy Today and Tomorrow. Diseases 7:2, pages 37.
Crossref
Crossref
Sara Artusi, Yoshitaka Miyagawa, William Goins, Justus Cohen & Joseph Glorioso. (2018) Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System. Diseases 6:3, pages 74.
Crossref
Crossref
Rosana P. Rota, Carlos A. Palacios, C. Facundo Temprana, Marcelo H. Argüelles, Marcelo G. Mandile, Nora Mattion, Andrea S. Laimbacher, Cornell Fraefel, Alejandro A. Castello & Graciela Glikmann. (2018) Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein. Journal of Virological Methods 256, pages 24-31.
Crossref
Crossref
Pablo Chamero & Frank Zufall. 2018. Olfactory Receptors. Olfactory Receptors
43
56
.
Linnet Ramos, Jacqueline E. Hunter & John H. Wolfe. 2017. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Drug and Gene Delivery to the Central Nervous System for Neuroprotection
89
125
.
Benjamin Stein, María Teresa Alonso, Frank Zufall, Trese Leinders-Zufall & Pablo Chamero. (2016) Functional Overexpression of Vomeronasal Receptors Using a Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon. PLOS ONE 11:5, pages e0156092.
Crossref
Crossref
Rachel D. Penrod, Audrey M. Wells, William A. CarlezonJr.Jr. & Christopher W. Cowan. (2015) Use of Adeno‐Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice. Current Protocols in Neuroscience 73:1.
Crossref
Crossref
Mohamed Labib Salem, Kamal Kamal Elsayed Gadalla, Burtram C. Fielding & Steve H. Thorne. 2015. Cancer Immunology. Cancer Immunology
131
150
.
YOONKHEI HO & HENG-PHON TOO. (2015) CATIONIC POLYMER BASED GENE DELIVERY: UPTAKE AND INTRACELLULAR TRAFFICKING. COSMOS 10:01, pages 17-24.
Crossref
Crossref
Carlos Palacios, Susana Torioni de Echaide & Nora Mattion. (2014) Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein. Research in Veterinary Science 97:3, pages 514-520.
Crossref
Crossref
Moriah L. Szpara, Derek Gatherer, Alejandro Ochoa, Benjamin Greenbaum, Aidan Dolan, Rory J. Bowden, Lynn W. Enquist, Matthieu Legendre & Andrew J. Davison. (2014) Evolution and Diversity in Human Herpes Simplex Virus Genomes. Journal of Virology 88:2, pages 1209-1227.
Crossref
Crossref
Aldo Pourchet, Matias E. Melendez, Anna Greco & Alberto L. Epstein. 2014. Viral Vector Approaches in Neurobiology and Brain Diseases. Viral Vector Approaches in Neurobiology and Brain Diseases
51
93
.
Yaroslav Gelfand & Michael G. Kaplitt. (2013) Gene Therapy for Psychiatric Disorders. World Neurosurgery 80:3-4, pages S32.e11-S32.e18.
Crossref
Crossref
K C Sia, H Huynh, N Chinnasamy, K M Hui & P Y P Lam. (2011) Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging. Gene Therapy 19:5, pages 532-542.
Crossref
Crossref
Diana Jerusalinsky, María Verónica Baez & Alberto Luis Epstein. (2012) Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases. Journal of Physiology-Paris 106:1-2, pages 2-11.
Crossref
Crossref
Kenichi Umene & Yasuyuki Fukumaki. (2011) DNA genome of spontaneously occurring deletion mutants of herpes simplex virus type 1 lacking one copy of the inverted repeat sequences of the L component. Archives of Virology 156:8, pages 1305-1315.
Crossref
Crossref
David C Gaston, Richard J Whitley & Jacqueline N Parker. (2011) Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery. Future Virology 6:3, pages 321-340.
Crossref
Crossref
Cornel Fraefel, Peggy Marconi & Alberto L. Epstein. 2011. Viral Vectors for Gene Therapy. Viral Vectors for Gene Therapy
303
343
.
Alejandra D’Antuono, Andrea S. Laimbacher, Jose La Torre, Virginia Tribulatti, Carina Romanutti, Patricia Zamorano, Valeria Quattrocchi, Elisabeth M. Schraner, Mathias Ackermann, Cornel Fraefel & Nora Mattion. (2010) HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 28:46, pages 7363-7372.
Crossref
Crossref
Paul E. Lund, Ryan C. Hunt, Michael M. Gottesman & Chava Kimchi-Sarfaty. (2009) Pseudovirions as Vehicles for the Delivery of siRNA. Pharmaceutical Research 27:3, pages 400-420.
Crossref
Crossref
Daisuke Watanabe. (2010) Medical application of herpes simplex virus. Journal of Dermatological Science 57:2, pages 75-82.
Crossref
Crossref
Joanna L. Howarth, Youn Bok Lee & James B. Uney. (2009) Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). Cell Biology and Toxicology 26:1, pages 1-20.
Crossref
Crossref
Alessandro Papale, Milica Cerovic & Riccardo Brambilla. (2009) Viral vector approaches to modify gene expression in the brain. Journal of Neuroscience Methods 185:1, pages 1-14.
Crossref
Crossref
E. Tsitoura, J. Thomas, D. Cuchet, K. Thoinet, P. Mavromara & A. L. Epstein. (2009) Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. Journal of General Virology 90:9, pages 2209-2220.
Crossref
Crossref
Kathleen A. Maguire-Zeiss & Howard J. Federoff. (2008) Immune-Directed Gene Therapeutic Development for Alzheimer’s, Prion, and Parkinson’s Diseases. Journal of Neuroimmune Pharmacology 4:3, pages 298-308.
Crossref
Crossref
A L Epstein. (2009) Progress and prospects: Biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Gene Therapy 16:6, pages 709-715.
Crossref
Crossref
Aartjan JW te Velthuis. (2009) Large virus for an even bigger task: can the mimivirus close the gene-therapy vector void?. Future Virology 4:3, pages 231-239.
Crossref
Crossref
Alberto Luis Epstein. (2009) HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties - a review. Memórias do Instituto Oswaldo Cruz 104:3, pages 399-410.
Crossref
Crossref
D Bouard, N Alazard-Dany & F-L Cosset. (2009) Viral vectors: from virology to transgene expression. British Journal of Pharmacology 157:2, pages 153-165.
Crossref
Crossref
Sabine Schenck, Elke Kehm, Alberto L. Epstein, Hanswalter Zentgraf, Martin Müller & Charles W. Knopf. (2008) Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors. Virus Genes 37:2, pages 131-143.
Crossref
Crossref